Delayed nausea and vomiting are awful side-effects of breast cancer chemotherapy. Nausea is rated as the most distressing side effect and vomiting the third most distressing by patients receiving chemotherapy. Between half and 80 percent of patients suffer these side-effects.
We've committed $250,000 to a new clinical trial that will test the availability of a cheap, widely available drug to prevent them. The PantoCIN trial, lead by medical oncologists Richard Isaacs and Navin Wewala from Palmerston North Hopsital, will recruit 164 patients at up to nine hospitals around New Zealand.